Maybe the End to L'Affaire Nemeroff?

For those of you who are sick and tired of my posting about Dr. Charles Nemeroff and his misdeeds, good news--we may finally have reached the effective end of this saga. The quickest way to access the key documents is via Sen. Charles Grassley's website at the Senate Finance Committee:

http://finance.senate.gov/sitepages/grassley.htm

Under the date "12-22-08" you will see three links, to a letter from Emory University; to a letter from Emory to the NIH; and to a comment by Grassley on both of the above.

Basically, Emory says that it has completed an initial investigation of Dr. Nemeroff and his unreported income from drug companies. The outcomes: He is to resign permanently as chair of Psychiatry; he is to be banned from any NIH study for two years; he is banned from accepting any money for speaking at events other than formal CME programs; and (according to the NIH letter) he is in a number of other ways being put on a very short leash and will be required to have the administration approve virtually his every move in relationship to accepting money or working with industry.

The Emory letter notes that Dr. Nemeroff believes that he was not required to report his speakers' fees under the then-existing Emory policy. He is quoted as expressing regret for his past actions and promising full cooperation with this new regime.

If things are as they appear then one of the most egregious flaunters of ethical propriety in the relationship between medicine and the pharmaceutical industry has at last been laid low.